These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 39223776)
1. TP53AIP1 induce autophagy via the AKT/mTOR signaling pathway in the breast cancer cells. Liu S; Xu T; Chen X; Tang L; Li L; Zhang L; Yang Y; Huang J Cancer Biol Ther; 2024 Dec; 25(1):2398297. PubMed ID: 39223776 [TBL] [Abstract][Full Text] [Related]
2. Plac8-mediated autophagy regulates nasopharyngeal carcinoma cell function via AKT/mTOR pathway. Huang ML; Qi CL; Zou Y; Yang R; Jiang Y; Sheng JF; Kong YG; Tao ZZ; Chen SM J Cell Mol Med; 2020 Jul; 24(14):7778-7788. PubMed ID: 32468683 [TBL] [Abstract][Full Text] [Related]
3. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823 [TBL] [Abstract][Full Text] [Related]
4. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685 [TBL] [Abstract][Full Text] [Related]
5. KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis. Zhang Y; Liu JL; Wang J Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3085-3096. PubMed ID: 32271426 [TBL] [Abstract][Full Text] [Related]
6. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling. Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473 [TBL] [Abstract][Full Text] [Related]
7. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMT. Guefack MF; Talukdar D; Mukherjee R; Guha S; Mitra D; Saha D; Das G; Damen F; Kuete V; Murmu N J Ethnopharmacol; 2024 Jan; 319(Pt 1):117093. PubMed ID: 37634746 [TBL] [Abstract][Full Text] [Related]
8. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058 [TBL] [Abstract][Full Text] [Related]
9. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973 [TBL] [Abstract][Full Text] [Related]
10. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway. Bi QJ; Men XJ; Han R; Li GL Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252 [TBL] [Abstract][Full Text] [Related]
11. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways. Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273 [TBL] [Abstract][Full Text] [Related]
12. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling. Zheng D; Ning J; Deng H; Ruan Y; Cheng F J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612 [TBL] [Abstract][Full Text] [Related]
13. MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway. Li Z; Li C; Wu Q; Tu Y; Wang C; Yu X; Li B; Wang Z; Sun S; Sun S Cell Death Dis; 2021 Jan; 12(1):97. PubMed ID: 33462219 [TBL] [Abstract][Full Text] [Related]
14. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer. Zhang M; Wang J; Guo Y; Yue H; Zhang L J Ovarian Res; 2023 Dec; 16(1):240. PubMed ID: 38115063 [TBL] [Abstract][Full Text] [Related]
15. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225 [TBL] [Abstract][Full Text] [Related]
16. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Zhou J; Jiang YY; Chen H; Wu YC; Zhang L Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522 [TBL] [Abstract][Full Text] [Related]
17. GABARAP suppresses EMT and breast cancer progression via the AKT/mTOR signaling pathway. Liu Y; Wang D; Lei M; Gao J; Cui Y; Jin X; Yu Q; Jiang Y; Guo Y; Liu Y; Cai L; Chen X Aging (Albany NY); 2021 Feb; 13(4):5858-5874. PubMed ID: 33591943 [TBL] [Abstract][Full Text] [Related]
18. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis. Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706 [TBL] [Abstract][Full Text] [Related]
19. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway. Wang Y; Mang X; Li D; Chen Y; Cai Z; Tan F Free Radic Biol Med; 2023 Nov; 208():134-152. PubMed ID: 37543168 [TBL] [Abstract][Full Text] [Related]
20. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]